Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices 80305 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. 

Matters To Be Considered: The agenda 

will include discussions on the 

following: NIOSH Program Update; 

Department of Labor (DOL) Program 

Update; Department of Energy (DOE) 

Program Update; Special Exposure 

Cohort (SEC) Petitions Update; 

Background and Update on 

Subcommittee for Procedures Review 

Activities; Pinellas Workgroup Update, 

Metals and Control Workgroup Update, 

Dose Reconstruction Review Methods 

Workgroup Update, and a Board Work 

Session. Agenda items are subject to 

change as priorities dictate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–25460 Filed 11–16–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Injury Prevention 

and Control 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of closed meeting. 

SUMMARY: In accordance with regulatory 

provisions, the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

Board of Scientific Counselors, National 

Center for Injury Prevention and Control 

(BSC, NCIPC or Board). This meeting is 

partially open to the public. 

DATES: The meeting will be held on 

January 11, 2024. The first session of the 

day will be held from 10 a.m. to 12:05 

p.m., EST (OPEN), and the second 

session will be held from 1 p.m. to 4:30 

p.m., EST (CLOSED). The public 

comment period will be at the end of 

the open session of the meeting, from 

11:45 a.m. to 12:00 p.m., EST. 

ADDRESSES: Webinar, Atlanta, Georgia. 

All participants must register by using 

the following link to attend the open 

session: https://cdc.zoomgov.com/ 

meeting/register/vJItf-igpjopGsXuGU

hsdlIOmRCB2yx509k. 

FOR FURTHER INFORMATION CONTACT: 

Christopher R. Harper, Ph.D., 

Designated Federal Officer, Board of 

Scientific Counselors, National Center 

for Injury Prevention and Control, 

Centers for Disease Control and 

Prevention, 4770 Buford Highway NE, 

Mailstop S–1069, Atlanta, Georgia 

30341. Telephone: (404) 718–8330; 

Email: ncipcbsc@cdc.gov. 

SUPPLEMENTARY INFORMATION: Portions 

of the meeting referenced above will be 

closed to the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5, U.S.C., and 

the Determination of the Director, Office 

of Strategic Business Initiatives, Office 

of the Chief Operating Officer, Centers 

for Disease Control and Prevention, 

pursuant to 5 U.S.C. 1009 (Pub. L. 92– 

463, as amended). 

Purpose: The Board of Scientific 

Counselors, National Center for Injury 

Prevention and Control (BSC, NCIPC or 

Board) will: (1) conduct, encourage, 

cooperate with, and assist other 

appropriate public health authorities, 

scientific institutions, and scientists in 

the conduct of research, investigations, 

experiments, demonstrations, and 

studies relating to the causes and 

strategies related to the prevention of 

injury, overdose, and violence; (2) assist 

States and other entities in preventing 

intentional and unintentional injuries, 

and to promote health and well-being; 

and (3) make recommendations of grants 

and cooperative agreements for research 

and prevention activities related to 

injury, overdose, and violence. The 

BSC, NCIPC makes recommendations 

regarding policies, strategies, objectives, 

and priorities and reviews progress 

toward injury, overdose, and violence 

prevention. The Board also provides 

advice on the appropriate balance of 

intramural and extramural research and 

provides guidance on the needs, 

structure, progress, and performance of 

intramural programs. Further, the Board 

provides guidance on extramural 

scientific program matters. 

Additionally, the Board provides 

second-level scientific and 

programmatic review of applications for 

research grants, cooperative agreements, 

and training grants related to injury, 

overdose, and violence prevention, and 

recommends approval of projects that 

merit further consideration for funding 

support. The Board also provides 

feedback and input on strategic plans, 

resources, and priority publications 

related to injury, overdose, and violence 

prevention. 

Matters To Be Considered: The open 

session of the meeting will include a 

discussion on the updated Intimate 

Partner Violence Research Priorities. 

The closed session of the meeting will 

focus on the secondary peer review of 

extramural research grant applications 

received in response to one (1) Notice of 

Funding Opportunity: RFA–CE–24– 

001—‘‘Grants for Injury Control 

Research Centers.’’ Agenda items are 

subject to change as priorities dictate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–25456 Filed 11–16–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2023–N–4807] 

General Hospital and Personal Use 

Devices Panel of the Medical Devices 

Advisory Committee; Notice of 

Meeting; Establishment of a Public 

Docket; Request for Comments—506J 

Device List 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; establishment of a 

public docket; request for comments. 

SUMMARY: The Food and Drug 

Administration (FDA) announces a 

forthcoming public advisory committee 

meeting of the General Hospital and 

Personal Use Devices Panel of the 

Medical Devices Advisory Committee 

(the Committee). The general function of 

the Committee is to provide advice and 

recommendations to FDA on regulatory 

issues. The meeting will be open to the 

public. FDA is establishing a docket for 

public comment on this document. 


khammond on DSKJM1Z7X2PROD with NOTICES